Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. (22nd January 2021)
- Record Type:
- Journal Article
- Title:
- Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. (22nd January 2021)
- Main Title:
- Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients
- Authors:
- Hasan, Syed Shahzad
Kow, Chia Siang
Bain, Amie
Kavanagh, Sallianne
Merchant, Hamid A.
Hadi, Muhammad Abdul - Abstract:
- ABSTRACT: Introduction: Diabetes mellitus is one of the most prevalent comorbidities identified in patients with coronavirus disease 2019 (COVID-19). This article aims to discuss the pharmacotherapeutic considerations for the management of diabetes in hospitalized patients with COVID-19. Areas covered: We discussed various aspects of pharmacotherapeutic management in hospitalized patients with COVID-19: (i) susceptibility and severity of COVID-19 among individuals with diabetes, (ii) glycemic goals for hospitalized patients with COVID-19 and concurrent diabetes, (iii) pharmacological treatment considerations for hospitalized patients with COVID-19 and concurrent diabetes. Expert opinion: The glycemic goals in patients with COVID-19 and concurrent type 1 (T1DM) or type 2 diabetes (T2DM) are to avoid disruption of stable metabolic state, maintain optimal glycemic control, and prevent adverse glycemic events. Patients with T1DM require insulin therapy at all times to prevent ketosis. The management strategies for patients with T2DM include temporary discontinuation of certain oral antidiabetic agents and consideration for insulin therapy. Patients with T2DM who are relatively stable and able to eat regularly may continue with oral antidiabetic agents if glycemic control is satisfactory. Hyperglycemia may develop in patients with systemic corticosteroid treatment and should be managed upon accordingly.
- Is Part Of:
- Expert opinion on pharmacotherapy. Volume 22:Number 2(2021)
- Journal:
- Expert opinion on pharmacotherapy
- Issue:
- Volume 22:Number 2(2021)
- Issue Display:
- Volume 22, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 22
- Issue:
- 2
- Issue Sort Value:
- 2021-0022-0002-0000
- Page Start:
- 229
- Page End:
- 240
- Publication Date:
- 2021-01-22
- Subjects:
- Antidiabetic -- coronavirus 2019 (COVID-19) -- diabetes -- type 1 diabetes -- types 2 diabetes -- therapeutics
Chemotherapy -- Periodicals
615.5805 - Journal URLs:
- http://informahealthcare.com/ ↗
http://www.tandfonline.com/toc/ieop20/current ↗
http://informahealthcare.com ↗
http://titania.ashley-pub.com/vl=5663459/cl=52/nw=1/rpsv/journal/journal6_home.htm ↗ - DOI:
- 10.1080/14656566.2020.1837114 ↗
- Languages:
- English
- ISSNs:
- 1465-6566
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002956
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22648.xml